Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
JNJ
Johnson & Johnson JNJ
$235.13
โ–ฒ +1.07% 24H
41.8593.49145.14196.78248.432001-072007-102014-012020-032026-06

About

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience, cardiovasโ€ฆ

SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees138,200
TickerJNJ

Statistics

Market Cap$565.87B
Revenue (TTM)$94.19B
Net Income$26.80B
Net Margin28.5%
EPS$11.03
P/E27.62
P/S5.95
P/B7.06
EV/EBITDA17.68
ROE26.4%
Dividend Yield2.25%
Price$235.13

Data: Twelve Data ยท Revenue = mcap / P/S

Johnson & Johnson (JNJ) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap